05/06/2026
Congratulations to our CEO, Robert Fried, on his nomination for the 2026 LA Times Executive Leadership Awards.
With over a decade in bioscience and a track record spanning entrepreneurship and media, Rob has led Niagen Bioscience through a period of significant growth since becoming CEO in 2018—expanding the company’s reach and continuing to advance NAD+ and cellular health science.
Through the External Research Program, research across institutions like the NIH, Harvard, Mayo Clinic, and Cambridge is advancing Niagen and NAD+, supported by hundreds of collaborations and over 45+ human clinical trials.
This nomination reflects the momentum built under great leadership, and the impact of that work. A big thank you to Rob and the entire Niagen Bioscience team for making this nomination possible!
+